Stem cells in stroke treatment: The promise and the challenges

International Journal of Stroke

Volumn 7, Issue 5, 2012, Pages 426-434

  Sinden, John D ^a   Muir, Keith W ^b  

^a RENEURON LTD   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Chronic disease; Functional imaging; Ischemic stroke; Stem cells; Stroke; Therapy

Indexed keywords

BRAIN ISCHEMIA; HUMAN; MESENCHYMAL STROMA CELL; NEURAL STEM CELL; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REVIEW; STEM CELL TRANSPLANTATION; STROKE; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; CONSUMER PRODUCT SAFETY; DIFFUSION OF INNOVATION; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; PATIENT SAFETY; PATIENT SELECTION; PUBLIC OPINION; STEM CELL TRANSPLANTATION; STROKE; TREATMENT OUTCOME;

EID: 84862684751     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00840.x     Document Type: Review

References (55)

1. Gage FH. Mammalian neural stem cells. Science 2000; 287:1433-1438.
2. Horie N, Pereira MP, Niizuma K etal. Transplanted stem cell-secreted VEGF effects post-stroke recovery, inflammation, and vascular repair. Stem Cells 2011; 29:274-285.
3. Gilman S. Pharmacologic management of ischaemic stroke: relevance to stem cell therapy. Exp Neurol 2006; 199:28-36.
4. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4·5 after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
5. Freed CR, Greene PE, Breeze RE etal. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344:710-719.
6. Olanow CW, Goetz CG, Kordower JH etal. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003; 54:403-414.
7. Lindvall O, Kokaia Z. Recovery and rehabilitation in stroke: stem cells. Stroke 2004; 35:2691-2694.
8. Miljan EA, Sinden JD. Stem cell treatment of ischemic brain injury. Curr Opin Mol Ther 2009; 11:394-403.
9. Lindvall O, Kokaia Z. Stem cell research in stroke: how far from the clinic? Stroke 2011; 42:2369-2375.
10. Sinden JD, Stroemer P, Grigoryan G, Patel S, French SJ, Hodges H. Functional repair with neural stem cells. Novartis Found Symp 2000; 231:270-283.
11. Burns TC, Steinberg GK. Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther 2011; 11:447-461.
12. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke 2007; 38:817-826.
13. Andres RH, Choi R, Steinberg GK, Guzman R. Potential of adult neural stem cells in stroke therapy. Regen Med 2008; 3:893-905.
14. Hicks A, Schallert T, Jolkkonen J. Cell-based therapies and functional outcome in experimental stroke. Cell Stem Cell 2009; 5:139-140.
15. Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56:329-341.
16. Chopp M, Li Y, Zhang ZG. Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 2009; 40: S143-S145.
17. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37:275-283.
18. Modo M, Stroemer RP, Tang E, Patel S, Hodges H. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 2002; 33:2270-2278.
19. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair 2009; 23:895-909.
20. Markgraf CG, Green EJ, Watson B etal. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke 1994; 25:153-159.
21. Modo M, Stroemer RP, Tang E, Veizovic T, Sowniski P, Hodges H. Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J Neurosci Methods 2000; 104:99-109.
22. Hunter AJ, Hatcher J, Virley D etal. Functional assessments in mice and rats after focal stroke. Neuropharmacology 2000; 39:806-816.
23. Schallert T. Behavioral tests for preclinical intervention assessment. NeuroRx 2006; 3:497-504.
24. Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke 2001; 32:1012-1019.
25. Modo M, Rezaie P, Heuschling P, Patel S, Male DK, Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res 2002; 958:70-82.
26. Smith EJ, Stroemer RP, Gorenkova N etal. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells 2012; 30:785-796.
27. Pollock K, Stroemer P, Patel S etal. A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol 2006; 199:143-155.
28. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995; 23:1686-1690.
29. Hodges H, Pollock K, Stroemer P etal. Making stem cell lines suitable for transplantation. Cell Transplant 2007; 16:101-115.
30. Pollock K, Sinden J. Progressing neural stem cell lines to the clinic; in Shi Y, Clegg DO, SpringerLink (eds): Stem Cell Research and Therapeutics. Dordrecht, Springer, 2008:105-122.
31. Thomas RJ, Hope AD, Hourd P etal. Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotech Lett 2009; 31:1167-1172.
32. Stevanato L, Corteling RL, Stroemer P etal. c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain. BMC Neurosci 2009; 10:86-99.
33. Amariglio N, Hirshberg A, Scheithauer BW etal. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009; 6:e1000029.
34. Kalladka D, Muir KW. Stem cell therapy in stroke: designing clinical trials. Neurochem Int 2011; 59:367-370.
35. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005; 20:101-107.
36. Kondziolka D, Steinberg GK, Wechsler L etal. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005; 103:38-45.
37. Kondziolka D, Wechsler L, Goldstein S etal. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55:565-569.
38. Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L etal. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci 2009; 27:151-161.
39. Muir KW, Sinden J, Miljan E, Dunn L. Intracranial delivery of stem cells. Transl Stroke Res 2011; 2:266-271.
40. Bhasin A, Srivastava MVP, Kumaran SS etal. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra 2011; 1:93-104.
41. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010; 28:1099-1106.
42. Chen J, Li Y, Wang L etal. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32:1005-1011.
43. Detante O, Moisan A, Dimastromatteo J etal. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant 2009; 18:1369-1379.
44. Pendharkar AV, Chua JY, Andres RH etal. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010; 41:2064-2070.
45. Diederich NJ, Goetz CG. The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies. Neurology 2008; 71:677-684.
46. Williams A, Gill S, Varma T etal. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9:581-591.
47. Coupar F, Pollock A, Rowe P, Weir C, Langhorne P. Predictors of upper limb recovery after stroke: a systematic review and meta-analysis. Clin Rehabil 2011; 26:291-313.
48. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011; 42:825-829.
49. Karki K, Knight RA, Shen LH etal. Chronic brain tissue remodeling after stroke in rat: a 1-year multiparametric magnetic resonance imaging study. Brain Res 2010; 1360:168-176.
50. Darsalia V, Heldmann U, Lindvall O, Kokaia Z. Stroke-induced neurogenesis in aged brain. Stroke 2005; 36:1790-1795.
51. Minger SL, Ekonomou A, Carta EM, Chinoy A, Perry RH, Ballard CG. Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007; 2:69-74.
52. Darsalia V, Allison SJ, Cusulin C etal. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2011; 31:235-242.
53. Wolf SL, Winstein CJ, Miller JP etal. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006; 296: 2095-2104.
54. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: asystematic review. Lancet Neurol 2009; 8:741-754.
55. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57:874-882.